Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin

Exclusion Criteria

• •For patients who enter the study taking a stable dose of metformin, history of taking OAD medications other than metformin during the 8 weeks prior to screening or have been on insulin therapy within 1 year of screening
• •For patients who enter the study taking insulin, history of taking any other therapy outside of the stable insulin and up to 2 OAD medications for 8 weeks prior to screening.
• •Use of sulfonylureas during the 8 weeks prior to screening
• •Prior exposure to dapagliflozin or any sodium-glucose co-transporter 2 (SGLT-2) inhibitor
• •Ingestion of any medication know to affect glucose metabolism for \>7 consecutive days during the 3 months prior to screening
• •Ingestion of prescription or over the counter weight loss medication during 3 months prior to screening